Ad hoc announcement pursuant to Art. 53 LR
- Itvisma (onasemnogene abeparvovec-brve) demonstrated improved motor function and stabilization in patients regardless of SMA treatment history in Phase III studies
- One-time dose of Itvisma replaces SMN1…

Ad hoc announcement pursuant to Art. 53 LR

LAVAL, QC, Nov. 24, 2025 /PRNewswire/ – Alimentation Couche-Tard Inc. (“Couche-Tard” or the “Corporation”) (TSX: ATD) announces its results for its second quarter ended October…

About The Defender Brand
The Defender Brand embraces the impossible. Each member of the Defender family is purposefully designed, highly desirable and seriously durable. A modern‑day hero that respects the past but at the same time anticipates…

Insider Brief

Rising COMEX Gold Revisions Raise Questions | The Jerusalem PostJerusalem Post/Business & Innovation/Precious MetalsCOMEX gold open-interest revisions spike beyond normal levels, revealing hidden risks, delayed reporting, and structural stress in…

The SIOG 2025 Annual Conference brought together experts from medical oncology, geriatrics, surgery, nursing, and digital health to examine one of the most challenging and increasingly common scenarios in oncology: managing…
CINCINNATI–(BUSINESS WIRE)–Aussie is redefining curl care with the launch of Ultra Wonder, breaking the rules and challenging the notion that great hair requires a dozen products and hours of styling. As the brand’s first premium innovation,…